Abstract
Thirty-four patients resistant to cyclophosphamide and Adriamycin received hexamethylmelamine at one of two dose regimens: 6 mg/kg/day orally for 21 days every 4 weeks or 8 mg/kg/day orally for 21 days every 6 weeks. Only five patients responded. Tolerance to the drug was, however, satisfactory; nausea, pyrosis, and vomiting were the only frequent side effects. Myelosuppression occurred in only one case.
| Original language | English |
|---|---|
| Pages (from-to) | 1375-1377 |
| Number of pages | 3 |
| Journal | Cancer Treatment Reports |
| Volume | 63 |
| Issue number | 8 |
| Publication status | Published - 1979 |
ASJC Scopus subject areas
- Cancer Research
- Oncology